Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nebulized Furosemide for Pulmonary Inflammation in Intubated Patients With COVID-19 - A Phase 2/3 Study

NCT04588792 is registered in ClinicalTrials.gov with Dr. John Muscedere as lead sponsor.

NCT NCT04588792
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04588792 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nebulized Furosemide for Pulmonary Inflammation in Intubated Patients With COVID-19 - A Phase 2/3 Study
Lead sponsor
Dr. John Muscedere
Phase
Phase 2/3
Overall status
Terminated
Start date
April 16, 2021
Completion date
April 30, 2023
Enrollment
40 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, respiratory failure